Deutsche Bank AG Increases Stock Position in Alignment Healthcare, Inc. (NASDAQ:ALHC)

Deutsche Bank AG boosted its position in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 48.3% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 93,582 shares of the company's stock after acquiring an additional 30,489 shares during the quarter. Deutsche Bank AG's holdings in Alignment Healthcare were worth $1,053,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Barclays PLC raised its position in Alignment Healthcare by 144.1% during the third quarter. Barclays PLC now owns 193,446 shares of the company's stock valued at $2,287,000 after acquiring an additional 114,191 shares in the last quarter. Ballentine Partners LLC acquired a new stake in Alignment Healthcare during the fourth quarter valued at $121,000. SG Americas Securities LLC grew its position in Alignment Healthcare by 11.7% during the fourth quarter. SG Americas Securities LLC now owns 49,272 shares of the company's stock valued at $554,000 after buying an additional 5,163 shares during the period. R Squared Ltd purchased a new position in Alignment Healthcare in the fourth quarter valued at $55,000. Finally, Allspring Global Investments Holdings LLC raised its position in shares of Alignment Healthcare by 1,672.5% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 656,637 shares of the company's stock worth $7,591,000 after acquiring an additional 619,592 shares during the period. Hedge funds and other institutional investors own 86.19% of the company's stock.

Insider Activity at Alignment Healthcare

In other news, President Dawn Christine Maroney sold 230,000 shares of the stock in a transaction dated Monday, April 14th. The stock was sold at an average price of $19.10, for a total value of $4,393,000.00. Following the transaction, the president now owns 2,132,899 shares in the company, valued at approximately $40,738,370.90. This represents a 9.73% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO John E. Kao sold 90,000 shares of the business's stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $14.84, for a total value of $1,335,600.00. Following the sale, the chief executive officer now owns 1,913,100 shares of the company's stock, valued at approximately $28,390,404. The trade was a 4.49% decrease in their position. The disclosure for this sale can be found here. Insiders sold 19,166,977 shares of company stock worth $294,801,511 in the last three months. 7.00% of the stock is owned by company insiders.

Alignment Healthcare Trading Up 2.1%

ALHC traded up $0.32 during trading hours on Friday, reaching $15.22. The company's stock had a trading volume of 607,828 shares, compared to its average volume of 1,962,972. The stock has a market cap of $3.01 billion, a PE ratio of -19.75 and a beta of 1.32. Alignment Healthcare, Inc. has a fifty-two week low of $7.05 and a fifty-two week high of $21.06. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.60 and a quick ratio of 1.60. The business's 50-day moving average is $17.03 and its 200-day moving average is $14.67.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.07. The firm had revenue of $926.93 million for the quarter, compared to analyst estimates of $889.83 million. Alignment Healthcare had a negative net margin of 5.84% and a negative return on equity of 108.69%. Alignment Healthcare's revenue was up 47.5% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.25) EPS. As a group, equities research analysts predict that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Analysts Set New Price Targets

ALHC has been the topic of a number of recent analyst reports. Barclays increased their price target on Alignment Healthcare from $8.00 to $9.00 and gave the stock an "underweight" rating in a research report on Friday, February 28th. Robert W. Baird increased their price objective on shares of Alignment Healthcare from $17.00 to $22.00 and gave the company an "outperform" rating in a report on Tuesday, April 15th. William Blair reiterated an "outperform" rating on shares of Alignment Healthcare in a research report on Friday, February 28th. UBS Group lifted their price objective on Alignment Healthcare from $16.00 to $17.00 and gave the stock a "neutral" rating in a report on Friday, May 2nd. Finally, Bank of America lifted their price target on Alignment Healthcare from $15.50 to $18.50 and gave the stock a "buy" rating in a research note on Tuesday, March 4th. One analyst has rated the stock with a sell rating, three have issued a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $17.17.

Alignment Healthcare Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.